Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill
Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.
Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.